BBIO Net Income Growth
Period ending:
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
BBIO net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 10.3263% | |
| -8.6769% | |
| -36.125% | |
| -81.6338% | |
| -71.0847% | |
| -24.0972% | |
| 16.7039% | |
| 28.3663% | |
| 20.7974% | |
| -26.6672% | |
| -33.671% | |
| -24.8337% | |
| -12.4901% | |
| 28.6839% | |
| 14.4623% | |
| 8.3263% | |
| -2.8465% | |
| -14.5982% | |
| -25.3641% | |
| -33.1033% | |
| -43.0077% | |
| -78.5657% | |
| -72.243% | |
| -78.2008% | |
| -75.6892% | |
| -84.5523% | |
| -99.2505% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All BBIO financial metrics · BBIO stock overview · How to interpret financial metrics